Mark A. Prygocki Sr.

This profile gathers the share dealings of Mark A. Prygocki Sr. across 2 companies, led by Medicis Pharmaceutical Corp and Clarus Therapeutics Holdings, Inc. In total, 50 filings cover trades dated from 7 February 2006 to 7 June 2022.

Both buying and selling appear: 1 purchase worth €46k, against 12 sales worth €4.2M. On balance, insiders were net sellers of €4.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 29 share grants and 5 option exercises.

The latest filing, published on 9 June 2022, reports a share grant in Clarus Therapeutics Holdings, Inc. The most recent open-market purchase was published on 1 June 2006, 7,450 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.